重度卵巢型子宫内膜异位症中子宫内膜基质细胞炎症表型与子宫内膜异位症相关不孕的关系
研究比较原发不孕患者中重度卵巢型子宫内膜异位症与无子宫内膜异位症者子宫内膜基质细胞在种植窗期的炎症因子分泌谱,发现卵巢型子宫内膜异位症组多种炎症因子升高、部分因子仅在该组可检测到,并呈现增殖增强表型,作者认为可能因此导致生育力丧失。
要点
- 重度卵巢型子宫内膜异位症患者子宫内膜基质细胞在种植窗期呈现高炎症分泌谱。
- CCL3、CCL4、CCL5、CXCL10、FGF2、IFNG、IL1RN、IL5、TNFA和VEGF仅在卵巢型子宫内膜异位症组条件培养基中可检测到。
- 卵巢型子宫内膜异位症组子宫内膜基质细胞体外增殖增强(P = 0.046),迁移能力无变化。
核心结论
- 作者认为重度卵巢型子宫内膜异位症来源的子宫内膜基质细胞在种植窗期呈现高炎症和高增殖倾向,可能因此导致生育力丧失。
研究设计与样本
- 研究纳入原发不孕患者,无子宫内膜异位症者为对照组(n = 12),IV期卵巢型子宫内膜异位症者为卵巢型子宫内膜异位症组(n = 14),用多因子检测法测定分离的子宫内膜基质细胞条件培养基中48种细胞因子。
- 对分泌谱有差异的关键细胞因子用蛋白质印迹法验证。
- 体外细胞表型验证比较对照组(n = 6)与卵巢型子宫内膜异位症组(n = 7)的增殖和迁移能力。
主要发现
- CCL3、CCL4、CCL5、CXCL10、FGF2、IFNG、IL1RN、IL5、TNFA和VEGF仅在卵巢型子宫内膜异位症组基质细胞条件培养基中可检测到。
- 两组条件培养基中均可检测到的细胞因子中,卵巢型子宫内膜异位症组CCL2(P = 0.0018)、CSF3(P = 0.0017)、IL1B(P = 0.0066)、IL4(P = 0.036)、IL6(P = 0.0039)和IL13(P = 0.036)较高,而IL18较低(P = 0.023)。
- 条件培养基中CCL2、IL1B、IL4和IL13浓度对预测卵巢型子宫内膜异位症表现出显著诊断性能。
- 体外细胞表型验证显示卵巢型子宫内膜异位症组子宫内膜基质细胞增殖表型增强(P = 0.046),细胞迁移能力无变化。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: Do endometrial stromal cells from primary infertile patients with severe ovarian endometriosis display differential secretory profiles of inflammation-associated cytokines during the implantation window that may cause infertility? DESIGN: Forty-eight cytokines were measured in conditioned medium of isolated endometrial stromal cells obtained from primary infertile patients without endometriosis (control group, n = 12) or with stage IV ovarian endometriosis (ovarian endometriosis group, n = 14) using multiplex assays. Key cytokines showing differential secretory profiles were validated using Western immunoblotting. Cellular phenotypic validation was carried out in vitro by comparing proliferation and migration capacity between control (n = 6) and ovarian endometriosis (n = 7) groups. RESULTS: CCL3, CCL4, CCL5, CXCL10, FGF2, IFNG, IL1RN, IL5, TNFA, and VEGF could be detected only in the conditioned media of stromal cells obtained from the ovarian endometriosis group. Among other cytokines detected in the conditioned media of both groups, CCL2 (P = 0.0018), CSF3 (P = 0.0017), IL1B (P = 0.0066), IL4 (P = 0.036), IL6 (P = 0.0039) and IL13 (P = 0.036) were found to be higher, whereas the concentration of IL18 was lower (P = 0.023) in the ovarian endometriosis group. Concentrations of CCL2, IL1B, IL4 and IL13 in conditioned medium reflected significant diagnostic performance for predicting ovarian endometriosis. Cellular phenotypic validation in vitro revealed an enhanced proliferative phenotype (P = 0.046) with no change in cell migratory capacity of endometrial stromal cells from the ovarian endometriosis group. CONCLUSIONS: Endometrial stromal cells derived from severe ovarian endometriosis samples displayed a hyperinflammatory and hyperproliferative bias in the endometrial stroma during the 'window of implantation' putatively causing loss of fecundability.
引用
- Anupa G, Poorasamy J, Bhat MA, et al. Endometrial stromal cell inflammatory phenotype during severe ovarian endometriosis as a cause of endometriosis-associated infertility. Reprod Biomed Online. 2020. PMID: 32792135. doi:10.1016/j.rbmo.2020.05.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。